HEADER ANTITUMOR PROTEIN 05-SEP-07 2JUY TITLE NMR ENSEMBLE OF NEOPETROSIAMIDE A COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEOPETROSIAMIDE A; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NEOPETROSIA SP. KEYWDS AMPHIPATHIC, ANTITUMOR PROTEIN EXPDTA SOLUTION NMR NUMMDL 24 AUTHOR P.AUSTIN,D.E.WILLIAMS,M.HELLER,L.P.MCINTOSH,R.J.ANDERSEN, AUTHOR 2 M.ROBERGE,C.D.ROSKELLEY REVDAT 2 24-FEB-09 2JUY 1 VERSN REVDAT 1 26-AUG-08 2JUY 0 JRNL AUTH P.AUSTIN,D.E.WILLIAMS,M.HELLER,L.P.MCINTOSH, JRNL AUTH 2 R.J.ANDERSEN,M.ROBERGE,C.D.ROSKELLEY JRNL TITL NMR ENSEMBLE OF NEOPETROSIAMIDE A JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNSSOLVE REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JUY COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-07. REMARK 100 THE RCSB ID CODE IS RCSB100322. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 8 MM NEOPETROSIAMIDE A, 4:1 REMARK 210 MECN-D3/H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC, 2D 1H-13C REMARK 210 HSQC, 2D 1H-1H NOESY, 2D 13C- REMARK 210 1H HSQC-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA, AVANCE REMARK 210 SPECTROMETER MANUFACTURER : VARIAN, BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SPARKY, ARIA, REMARK 210 CNSSOLVE REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 24 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 5 25.74 -150.42 REMARK 500 1 VAL A 10 -74.37 -102.26 REMARK 500 1 ASP A 11 31.23 -150.18 REMARK 500 1 CYS A 12 -39.05 177.30 REMARK 500 1 ASN A 15 -52.57 -145.10 REMARK 500 2 PHE A 5 -67.01 -146.07 REMARK 500 2 VAL A 10 -72.49 -102.72 REMARK 500 2 ASP A 11 31.62 -150.09 REMARK 500 2 CYS A 12 -38.44 176.04 REMARK 500 2 ASN A 15 -50.89 -146.14 REMARK 500 3 PHE A 5 22.95 -149.98 REMARK 500 3 VAL A 10 -87.80 -102.49 REMARK 500 3 ASP A 11 41.06 -150.62 REMARK 500 3 CYS A 12 -38.38 -175.79 REMARK 500 3 ASN A 15 -54.01 -143.67 REMARK 500 4 PHE A 5 49.44 -150.05 REMARK 500 4 CYS A 7 39.30 -89.54 REMARK 500 4 VAL A 10 -80.67 -101.12 REMARK 500 4 ASP A 11 30.34 -150.50 REMARK 500 4 CYS A 12 30.85 171.97 REMARK 500 4 ASN A 15 23.61 -150.08 REMARK 500 5 PHE A 5 -65.60 -135.73 REMARK 500 5 CYS A 7 41.63 -90.46 REMARK 500 5 LEU A 9 41.14 -148.05 REMARK 500 5 VAL A 10 -77.33 -118.77 REMARK 500 5 ASP A 11 37.00 -150.44 REMARK 500 5 CYS A 12 27.69 173.62 REMARK 500 5 ASN A 15 -46.34 -146.24 REMARK 500 6 PHE A 5 -56.68 -139.64 REMARK 500 6 CYS A 7 39.23 -90.41 REMARK 500 6 VAL A 10 -88.16 -103.03 REMARK 500 6 ASP A 11 38.42 -150.56 REMARK 500 6 CYS A 12 21.19 -176.80 REMARK 500 6 ASN A 15 -56.17 -135.41 REMARK 500 7 PHE A 5 -68.79 -127.98 REMARK 500 7 CYS A 7 -74.86 -89.17 REMARK 500 7 ALA A 8 72.48 71.98 REMARK 500 7 VAL A 10 -75.87 -108.49 REMARK 500 7 ASP A 11 33.99 -150.26 REMARK 500 7 CYS A 12 -28.97 176.08 REMARK 500 7 ASN A 15 -63.58 -142.34 REMARK 500 8 PHE A 5 -65.88 -144.12 REMARK 500 8 ALA A 8 -71.92 -49.17 REMARK 500 8 LEU A 9 33.11 -98.17 REMARK 500 8 VAL A 10 -88.54 -101.93 REMARK 500 8 ASP A 11 38.68 -150.72 REMARK 500 8 CYS A 12 -40.84 -177.54 REMARK 500 8 ASN A 15 -49.39 -140.88 REMARK 500 9 PHE A 5 -68.77 -125.40 REMARK 500 9 CYS A 7 -77.15 -90.12 REMARK 500 9 ALA A 8 73.01 73.38 REMARK 500 9 VAL A 10 -75.93 -110.29 REMARK 500 9 ASP A 11 34.16 -150.17 REMARK 500 9 CYS A 12 -31.57 176.32 REMARK 500 9 ASN A 15 -50.80 -144.42 REMARK 500 10 PHE A 5 -52.73 -149.68 REMARK 500 10 CYS A 7 39.14 -90.42 REMARK 500 10 VAL A 10 -77.22 -109.34 REMARK 500 10 ASP A 11 31.13 -150.45 REMARK 500 10 CYS A 12 -31.43 177.87 REMARK 500 10 PRO A 14 64.57 -68.38 REMARK 500 10 ASN A 15 -45.14 -150.06 REMARK 500 11 PHE A 5 -48.56 -141.90 REMARK 500 11 VAL A 10 -75.81 -103.94 REMARK 500 11 ASP A 11 31.88 -150.23 REMARK 500 11 CYS A 12 -38.96 178.80 REMARK 500 11 ASN A 15 -51.33 -142.70 REMARK 500 12 PHE A 5 -54.00 -149.84 REMARK 500 12 VAL A 10 -71.96 -126.95 REMARK 500 12 CYS A 12 31.23 37.08 REMARK 500 12 ASN A 15 -42.08 -150.00 REMARK 500 13 PHE A 5 -62.84 -133.50 REMARK 500 13 CYS A 7 41.96 -90.56 REMARK 500 13 ALA A 8 -73.72 -49.75 REMARK 500 13 VAL A 10 -85.88 -104.53 REMARK 500 13 ASP A 11 36.19 -150.78 REMARK 500 13 CYS A 12 28.81 171.28 REMARK 500 13 ASN A 15 -37.10 -150.05 REMARK 500 14 PHE A 5 -60.58 -123.94 REMARK 500 14 CYS A 7 41.41 -90.47 REMARK 500 14 ALA A 8 -75.90 -49.31 REMARK 500 14 LEU A 9 36.77 -94.04 REMARK 500 14 VAL A 10 -86.86 -106.75 REMARK 500 14 ASP A 11 37.89 -150.86 REMARK 500 14 CYS A 12 -44.38 -175.41 REMARK 500 14 ASN A 15 -31.83 -150.27 REMARK 500 15 PHE A 5 -48.89 -150.21 REMARK 500 15 CYS A 7 -78.10 -90.11 REMARK 500 15 ALA A 8 75.67 68.92 REMARK 500 15 VAL A 10 -79.55 -109.87 REMARK 500 15 ASP A 11 33.57 -150.25 REMARK 500 15 CYS A 12 -25.30 176.31 REMARK 500 15 PRO A 14 61.26 -69.82 REMARK 500 15 ASN A 15 -65.69 -135.96 REMARK 500 16 ALA A 8 -82.63 -50.46 REMARK 500 16 LEU A 9 43.51 -95.74 REMARK 500 16 VAL A 10 -84.35 -109.57 REMARK 500 16 ASP A 11 36.91 -150.70 REMARK 500 16 CYS A 12 -40.75 178.69 REMARK 500 16 ASN A 15 -32.40 -146.29 REMARK 500 17 PHE A 5 -47.63 -144.96 REMARK 500 17 VAL A 10 -86.66 -100.39 REMARK 500 17 ASP A 11 40.19 -150.65 REMARK 500 17 CYS A 12 -38.38 -176.92 REMARK 500 17 ASN A 15 -54.99 -139.53 REMARK 500 18 PHE A 5 -64.16 -144.62 REMARK 500 18 VAL A 10 -74.36 -99.93 REMARK 500 18 ASP A 11 31.54 -150.11 REMARK 500 18 CYS A 12 -37.60 177.03 REMARK 500 18 ASN A 15 -52.72 -147.06 REMARK 500 19 PHE A 5 -67.33 -138.76 REMARK 500 19 VAL A 10 -74.26 -97.62 REMARK 500 19 ASP A 11 31.65 -150.28 REMARK 500 19 CYS A 12 -37.72 178.52 REMARK 500 19 ASN A 15 -52.42 -149.91 REMARK 500 20 PHE A 5 -48.08 -142.36 REMARK 500 20 VAL A 10 -73.60 -100.40 REMARK 500 20 ASP A 11 31.17 -150.00 REMARK 500 20 CYS A 12 -36.66 175.58 REMARK 500 20 ASN A 15 -49.38 -141.85 REMARK 500 21 PHE A 5 -69.84 -128.95 REMARK 500 21 CYS A 7 39.58 -90.36 REMARK 500 21 ALA A 8 109.68 -56.45 REMARK 500 21 ASP A 11 27.55 -150.16 REMARK 500 21 CYS A 12 38.57 168.22 REMARK 500 21 ASN A 15 -53.03 -131.57 REMARK 500 22 CYS A 7 35.89 -86.52 REMARK 500 22 ASP A 11 30.99 -149.89 REMARK 500 22 CYS A 12 -42.55 173.74 REMARK 500 22 PRO A 14 58.93 -69.78 REMARK 500 22 ASN A 15 22.39 -150.20 REMARK 500 23 PHE A 5 29.12 -150.16 REMARK 500 23 LEU A 9 27.67 49.91 REMARK 500 23 VAL A 10 -68.45 -98.76 REMARK 500 23 ASP A 11 30.85 -149.78 REMARK 500 23 CYS A 12 -36.00 173.96 REMARK 500 23 ASN A 15 -34.54 -150.15 REMARK 500 24 PHE A 5 -59.27 -143.75 REMARK 500 24 VAL A 10 -74.23 -98.24 REMARK 500 24 ASP A 11 31.39 -150.25 REMARK 500 24 CYS A 12 -37.40 177.10 REMARK 500 24 ASN A 15 -46.53 -147.33 REMARK 500 REMARK 500 REMARK: NULL DBREF 2JUY A 1 28 PDB 2JUY 2JUY 1 28 SEQRES 1 A 28 PHE PHE CYS PRO PHE GLY CYS ALA LEU VAL ASP CYS GLY SEQRES 2 A 28 PRO ASN ARG PRO CYS ARG ASP THR GLY PHE SME SER CYS SEQRES 3 A 28 ASP CYS MODRES 2JUY SME A 24 MET METHIONINE SULFOXIDE HET SME A 24 18 HETNAM SME METHIONINE SULFOXIDE FORMUL 1 SME C5 H11 N O3 S SHEET 1 A 2 ARG A 19 ASP A 20 0 SHEET 2 A 2 CYS A 26 ASP A 27 -1 O ASP A 27 N ARG A 19 SSBOND 1 CYS A 3 CYS A 26 1555 1555 2.03 SSBOND 2 CYS A 7 CYS A 12 1555 1555 2.03 SSBOND 3 CYS A 18 CYS A 28 1555 1555 2.03 LINK C PHE A 23 N SME A 24 1555 1555 1.33 LINK C SME A 24 N SER A 25 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 209 0 1 0 2 0 0 6 0 0 0 3 END